Jean Villard

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Artificial Intelligence

High Throughput Sequencing

Top Venues

Cancer research communications

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sílvia Casas, Narin S Tangprasertchai, Katerina Oikonomaki, Simon Mathers, Zuleika Calderin Sollet, Stavroula Samara, June Liu, Natalia Diaz Burlinson, Pantelis Constantoulakis, Jean Villard, Thierry Viard
Multi-centre analytical performance verification of an IVD assay to quantify donor-derived cell-free DNA in solid organ transplant recipients. HLA 103 (5) (2024)
Antonia Schäfer, Zuleika Calderin Sollet, Marie-Priscille Hervé, Stephane Buhler, Sylvie Ferrari-Lacraz, Paul J Norman, Katherine M Kichula, Ticiana Della Justina Farias, Stavroula Masouridi-Levrat, Anne-Claire Mamez, Amandine Pradier, Federico Simonetta, Yves Chalandon, Jean Villard
NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation. Blood advances (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Sílvia Casas, Narin S Tangprasertchai, Katerina Oikonomaki, Simon Mathers, Zuleika Calderin Sollet, Stavroula Samara, June Liu, Natalia Diaz Burlinson, Pantelis Constantoulakis, Jean Villard, Thierry Viard
Multi-centre analytical performance verification of an IVD assay to quantify donor-derived cell-free DNA in solid organ transplant recipients. HLA 103 (5) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Antonia Schäfer, Zuleika Calderin Sollet, Marie-Priscille Hervé, Stephane Buhler, Sylvie Ferrari-Lacraz, Paul J Norman, Katherine M Kichula, Ticiana Della Justina Farias, Stavroula Masouridi-Levrat, Anne-Claire Mamez, Amandine Pradier, Federico Simonetta, Yves Chalandon, Jean Villard
NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation. Blood advances (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A first-in-human phase I clinical study with MVX-ONCO-1, a personalized active immunotherapy, in patients with advanced solid tumors. Cancer research communications (2024)
Stéphane Buhler, Zuleika Calderin Sollet, Florence Bettens, Antonia Schäfer, Marc Ansari, Sylvie Ferrari-Lacraz, Jean Villard
HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era. HLA (2023)
Daniel Yoo, Valentin Goutaudier, Gillian Divard, Juliette Gueguen, Brad C Astor, Olivier Aubert, Marc Raynaud, Zeynep Demir, Julien Hogan, Patricia Weng, Jodi Smith, Rouba Garro, Bradley A Warady, Rima S Zahr, Marta Sablik, Katherine E Twombley, Lionel Couzi, Thierry Berney, Olivia Boyer, Jean-Paul Duong-Van-Huyen, Magali Giral, Alaa Alsadi, Pierre A Gourraud, Emmanuel Morelon, Moglie Le Quintrec, Sophie Brouard, Christophe Legendre, Dany Anglicheau, Jean Villard, Weixiong Zhong, Nassim Kamar, Oriol Bestard, Arjang Djamali, Klemens Budde, Mark Haas, Carmen Lefaucheur, Marion Rabant, Alexandre Loupy
An automated histological classification system for precision diagnostics of kidney allografts. Nature medicine (2023)
Zuleika Calderin Sollet, Antonia Schäfer, Sylvie Ferrari-Lacraz, Stavroula Masouridi-Levrat, Anne-Claire Mamez, Amandine Pradier, Federico Simonetta, Yves Chalandon, Jean Villard, Stéphane Buhler
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation. Leukemia (2023)
Daniel Yoo, Valentin Goutaudier, Gillian Divard, Juliette Gueguen, Brad C Astor, Olivier Aubert, Marc Raynaud, Zeynep Demir, Julien Hogan, Patricia Weng, Jodi Smith, Rouba Garro, Bradley A Warady, Rima S Zahr, Marta Sablik, Katherine E Twombley, Lionel Couzi, Thierry Berney, Olivia Boyer, Jean-Paul Duong-Van-Huyen, Magali Giral, Alaa Alsadi, Pierre A Gourraud, Emmanuel Morelon, Moglie Le Quintrec, Sophie Brouard, Christophe Legendre, Dany Anglicheau, Jean Villard, Weixiong Zhong, Nassim Kamar, Oriol Bestard, Arjang Djamali, Klemens Budde, Mark Haas, Carmen Lefaucheur, Marion Rabant, Alexandre Loupy
An automated histological classification system for precision diagnostics of kidney allografts. Nature medicine 29 (5) (2023)
Florence Bettens, Halit Ongen, Guillaume Rey, Stéphane Buhler, Zuleika Calderin Sollet, Emmanouil Dermitzakis, Jean Villard
Regulation of HLA class I expression by non-coding gene variations. PLoS genetics 18 (6) (2022)